These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The intrauterine contraceptive device. Barwin BN; Tuttle S; Jolly EE Can Med Assoc J; 1978 Jan; 118(1):53-8. PubMed ID: 620385 [TBL] [Abstract][Full Text] [Related]
44. Progestasert - a new intrauterine contraceptive device. Med Lett Drugs Ther; 1976 Jul; 18(16):65-6. PubMed ID: 950949 [No Abstract] [Full Text] [Related]
45. Contraceptive devices: intravaginal and intrauterine delivery systems. Benagiano G; Gabelnick H; Farris M Expert Rev Med Devices; 2008 Sep; 5(5):639-54. PubMed ID: 18803474 [TBL] [Abstract][Full Text] [Related]
46. The Alza T IPCS 52, a longer acting progesterone IUD: safety and efficacy compared to the TCu22OC and multiload 250 in two randomized multicentre trials. The World Health Organization's special programme of research, development and research training in human reproduction. Task Force on intrauterine devices for fertility regulation. Clin Reprod Fertil; 1983 Jun; 2(2):113-28. PubMed ID: 6367929 [TBL] [Abstract][Full Text] [Related]
47. Fertility after IUD removal. Randic L; Vlasic S; Matrijan I Contracept Fertil Sex (Paris); 1978 May; 7(3):183-8. PubMed ID: 12335671 [TBL] [Abstract][Full Text] [Related]
48. Intrauterine contraception: the role of general practitioners in four Dutch general practices. Vos AA; Veldhuis HM; Lagro-Janssen TL Contraception; 2004 Apr; 69(4):283-7. PubMed ID: 15033402 [TBL] [Abstract][Full Text] [Related]
50. Mineral deposits formation in bioactive IUD's. Huacuja L; Delgado NM; Aznar R; Rosado A Adv Contracept Deliv Syst; 1987; 3(2-3):251-7. PubMed ID: 12268656 [TBL] [Abstract][Full Text] [Related]
51. Increased retention of intrauterine contraceptive devices medicated with indomethacin and medroxyprogesterone acetate. Von Dadelszen P; Hurst PR; Peplow PV Proc Univ Otago Med Sch; 1981 Oct; 59(3):101-3. PubMed ID: 12264137 [TBL] [Abstract][Full Text] [Related]
52. Intrauterine release of progesterone. II. Modification of macromolecular synthesis of endometrium. Hernandez O; Ballesteros LM; Aznar R; Delgado NM; Rosado A Contracept Deliv Syst; 1981 Oct; 2(4):319-25. PubMed ID: 12336993 [TBL] [Abstract][Full Text] [Related]
53. The modes of action of medicated intrauterine devices. Hagenfeldt K J Reprod Fertil Suppl; 1976 Oct; (25):117-32. PubMed ID: 827612 [No Abstract] [Full Text] [Related]
54. Contraception with intrauterine devices. Parr EL Bioscience; 1973 May; 23(5):281-6. PubMed ID: 4803454 [TBL] [Abstract][Full Text] [Related]
55. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)]. Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443 [TBL] [Abstract][Full Text] [Related]
58. Contraception by intrauterine release of steroids. Zaffaroni A J Steroid Biochem; 1975 Jun; 6(6):883. PubMed ID: 1177429 [No Abstract] [Full Text] [Related]
59. A prospective study of plasma prolactin levels in women using the progesterone releasing intrauterine device (P-IUD). Spellacy WN; Buhi WC Contraception; 1979 Jan; 19(1):91-4. PubMed ID: 428227 [TBL] [Abstract][Full Text] [Related]
60. Contraception by intrauterine release of progesterone--effects on endometrial trace elements, enzymes and steroids. Hagenfeldt K; Landgren BM J Steroid Biochem; 1975 Jun; 6(6):895-8. PubMed ID: 1177431 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]